Mylan submits new drug application to FDA
November 14, 2017 at 08:34 AM EST
A treatment for COPD was developed by the company and England-based Theravance Biopharma.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|